EDGAR Filing Documents for 0001209191-16-141534

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

SEC Accession No. 0001209191-16-141534

Filing Date

2016-09-15

Accepted

2016-09-15 14:29:53

Documents

Period of Report

2016-03-28

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4/A SUBMISSION	doc4a.html	4/A
1	FORM 4/A SUBMISSION	doc4a.xml	4/A	4390
2	POA DOCUMENT	poa.txt	EX-24.4A_675513	3096
	Complete submission text file	0001209191-16-141534.txt		8924

Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306

Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-279-9845

Eiger BioPharmaceuticals, Inc. (Issuer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE ENTERPRISE ALISO VIEJO CA 92656

Business Address

Type: 4/A | Act: 34 | File No.: 001-36183 | Film No.: 161886951